Significance of various parameters derived from biological variability of lipoprotein(a), homocysteine, cysteine, and total antioxidant status

Clinical Chemistry

Volumn 43, Issue 10, 1997, Pages 1958-1964

  Cobbaert, Christa ^a   Arentsen, Johannes C ^a   Mulder, Paul ^b   Hoogerbrugge, Nicoline ^a   Lindemans, Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CYSTEINE; HOMOCYSTEINE; LIPOPROTEIN A;

ADULT; AGED; AMINO ACID METABOLISM; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BIODIVERSITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOMOCYSTINURIA; HUMAN; HYPERLIPOPROTEINEMIA; ISCHEMIC HEART DISEASE; MALE; OXIDATIVE STRESS;

EID: 0030767123     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.10.1958     Document Type: Article

References (27)

1. Dahlèn GH. Lp(a) lipoprotein in cardiovascular disease [Review]. Atherosclerosis 1994;108:111-26.
2. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis [Review]. J Am Coll Cardiol 1996;27:517-27.
3. van Poppel G, Kardinaal A, Princen H, Kok FJ. Anti-oxidants and coronary heart disease [Review]. Ann Med 1994;26:429-34.
4. Cobbaert C, Deprost L, Mulder P, Rombaut K, Gijsels G, Kesteloot H. Pubertal serum Lp(a) and its correlates in Belgian schoolchildren. Int J Epidemiol 1995;24:78-87.
5. Cobbaert C, Sergeant P, Meyns B, Szécsi J, Kesteloot H. Time course of serum Lp(a) in men after coronary bypass grafting. Acta Cardiol 1992;47:529-42.
6. Cobbaert C, Kesteloot H. Serum lipoprotein(a) levels in racially different populations. Am J Epidemiol 1992;136:441-9.
7. Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI, et al. Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet 1995;345:405-9.
8. Malinow MR. Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review. Clin Chem 1995;41:173-6.
9. Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance [Review]. Curr Opinion Lipidol 1994;5:422-33.
10. Miller NJ, Rice-Evans CA, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993;84:407-12.
11. Fraser CG. Generation and application of analytical goals in laboratory medicine. Ann 1st Super Sanità 1991;27:369-76.
12. Fraser CG. Data on biological variation: essential prerequisites for introducing new procedures? [Editorial]. Clin Chem 1994;40: 1671-3.
13. Albers JJ, Adolphson JL, Hazzard WR. Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res 1977;18:331-8.
14. Chambless LE, McMahon RP, Brown SA, Patsch W, Heiss G, Li Shen Y. Short-term intraindividual variability in lipoprotein measurements: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epdemiol 1992;136:1069-81.
15. Pagani F, Panteghini M. Significance of various parameters derived from biological variability for lipid and lipoprotein analyses. Clin Biochem 1993;26:415-20.
16. Mackness MI, Bhatnagar D, Weiringa G, Mbewu A, Haynes B, Durrington PN. A comparative study of six commercial lipoprotein(a) assays in seventeen laboratories within the British Isles. Ann Clin Biochem 1996;33:63-70.
17. Glueck CJ, Tracy T, Sieve-Smith L, Wang P. Whether, to what degree, and why lipoprotein(a) levels change over time? Clin Chim Acta 1995;238:11-9.
18. Marcovina SM, Gaur VP, Albers JJ. Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-I and B. Clin Chem 1994;40: 574-8.
19. Marcovina SM, Lippi G, Bagatell CJ, Bremner WJ. Testosterone-induced suppression of lipoprotein(a) in normal men; relation to basal lipoprotein(a) level. Atherosclerosis 1996;122:89-95.
20. Queraltó JM, Boyd JC, Harris EK. On the calculation of reference change values, with examples from a long-term study. Clin Chem 1993;39:1398-403.
21. Panteghini M, Pagani F. Pre-analytical, analytical and biological sources of variation of lipoprotein(a). Eur J Clin Chem Clin Biochem 1993;31:23-38.
22. Miller NJ. Anticoagulants for total antioxidant activity assay [Letter]. Ann Clin Biochem 1996;33:92-4.
23. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.
24. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
25. Ubbink JB, Vermaak WJH, Bissbort S. Rapid high-performance liquid Chromatographic assay for total homocysteine in human serum. J Chromatogr 1991;565:441-6.
26. Harris EK. Proposed goals for analytical precision and accuracy using single-point diagnostic testing. Arch Pathol Lab Med 1988; 112:416-20.
27. Armitage P, Berry MA, eds. Statistical methods in medical research, 2nd ed. London: Blackwell Scientific Publications, 1987: 91-2.